Why Experimental Ebola Drug ZMapp Might Actually Work

When Dr. Kent Brantly, the first U.S. Ebola patient, contracted the deadly virus in 2014, physicians raced to give him a highly experimental drug called ZMapp. No one knew whether it would work — it was just a cocktail of mouse antibodies. Thankfully, Brantly, along with many others who took the drug, survived the ordeal. Now, after its first round of clinical trials, ZMapp is being considered the most promising potential treatment to prevent Ebola-related deaths.

Scientists aren’t...

What feeling does this article give you?

#hashtags to follow:

Brantly [+]    Ebola [+]    ZMapp [+]    Scientists [+]   

More #news: